iBio Appoints Molly Carr as Chief Medical Officer

Company: iBio · Event Type: Leadership Addition · Role: Chief Medical Officer · Incoming: Molly Carr, M.D. · Effective Date: July 31, 2026 Summary iBio appointed endocrinologist Molly Carr, M.D., as chief medical officer effective July 31, 2026 and announced the appointment on August 4.…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Tags
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *

Saturday Rounds

MeiraGTx – $400M Oberland Strategic Financing for Late-Stage Gene Therapy Programs
Beeline Therapeutics – $300M Launch
Repligen Buys BioLife for $1.5 Billion
Nurix + Roche; Global BTK Degrader Collaboration